NCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
Clinical Trials
7 trialsNCT05085561 2025-08-06
SYCAMORE
Recursion Pharmaceuticals Inc.
Phase 2 Completed
NCT07026604 2025-06-18
CCM-DS01
Beijing Tiantan Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05298709 2025-06-11
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
University of New Mexico
Phase NA Terminated
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT01764451 2024-03-12
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
University of New Mexico
Phase EARLY_PHASE1 Terminated
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed